These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7128188)

  • 1. Bromocriptine in depression.
    Bouras N; Bridges PK
    Curr Med Res Opin; 1982; 8(3):150-3. PubMed ID: 7128188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients.
    Waehrens J; Gerlach J
    J Affect Disord; 1981 Jun; 3(2):193-202. PubMed ID: 6454713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
    Theohar C; Fischer-Cornelssen K; Brosch H; Fischer EK; Petrovic D
    Arzneimittelforschung; 1982; 32(7):783-7. PubMed ID: 6751339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
    Gonella G; Baignoli G; Ecari U
    Curr Med Res Opin; 1990; 12(3):177-84. PubMed ID: 2125547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression.
    Faltus F; Geerling FC
    Neuropsychobiology; 1984; 12(1):34-8. PubMed ID: 6239991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.
    Katona C; Bercoff E; Chiu E; Tack P; Versiani M; Woelk H
    J Affect Disord; 1999 Oct; 55(2-3):203-13. PubMed ID: 10628889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nefazodone and imipramine in major depression: a placebo-controlled trial.
    Rickels K; Schweizer E; Clary C; Fox I; Weise C
    Br J Psychiatry; 1994 Jun; 164(6):802-5. PubMed ID: 7952987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression.
    Reifler BV; Teri L; Raskind M; Veith R; Barnes R; White E; McLean P
    Am J Psychiatry; 1989 Jan; 146(1):45-9. PubMed ID: 2643356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.
    Philipp M; Kohnen R; Hiller KO
    BMJ; 1999 Dec; 319(7224):1534-8. PubMed ID: 10591711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.